Material Type

• Blood (whole) (2)
• Buffy coat (1)
• Dried whole blood (2)
• Isolated peripheral blood mononuclear cells (non viable) (2)
• Isolated peripheral blood mononuclear cells (viable) (1)
• Other (2)
• Plasma (double spun) (2)
• Plasma (single spun) (2)
• Red Blood Cells (1)
• Serum (4)
• Stool (3)
• Urine (random) (3)

Microscopic Assessment

• Affected (2)
• Non-affected (1)
• Not applicable (4)

Storage Temperature

• -35°C to -18°C (2)
• -85°C to -60°C (4)
• Liquid nitrogen (1)

Preservation Type

• N/A (1)

Associated Data

• Biomarker datasets (1)
• Clinical records (3)
• Followup records (3)
• Freezer temperature logs (6)
• Microbiological results (1)
• Participant Ethnicity (1)
• Quality indicators (1)
• Survey data (3)
• Treatment records (3)

Timeframe

• Immediate (3)
• 0 - 3 months (6)
• 3 - 6 months (2)
• > 6 months (1)

Participant Count

• 1 - 10 (1)
• 11 - 100 (3)
• 101 - 500 (5)

Sex

• Both sexes (6)

Age Range

• Young child (2 - 6 years) (3)
• Child (6 - 12 years) (3)
• Adolescent (12 - 18 years) (3)
• Young adult (18 - 40 years) (3)
• Adult (> 40 years) (4)

Biobank Services

• Ability to recontact (2)
• Cell culture (2)
• Digital imaging (1)
• Infectious strain isolation (1)
• Molecular Extractions (2)
• Nucleic acid extraction (3)

Collection Type

• Cohort (2)
• Cross-sectional (3)
• Disease specific (1)

Consent Restriction

• No Commercial restriction (5)
• No Disease area restriction (5)
• No Export restriction (6)
• No Genetic analysis restriction (4)
• No Human genetic analysis restriction (4)
• No restrictions (1)
• No Project specific restriction (5)
• No Scope of use restriction (6)

Collection Status

• Completed (3)
• In progress (3)
• Not-started (1)

Access Condition

• Open only through collaboration (6)

Country

• Belgium (1)
• Ghana (1)
• Peru (2)
• Spain (1)
• Uganda (1)
• United States (1)

County